Keyphrases
Recombinant Interferon
100%
Phase II Trial
100%
Isotretinoin
100%
Metastatic Colorectal Cancer (mCRC)
100%
Interferon alpha-2b
100%
Squamous Cell Carcinoma of the Cervix
66%
Skin Squamous Cell Carcinoma
66%
Neurotoxicity
33%
Tumor
33%
Progressive Disease
33%
Therapeutic Action
33%
Colorectal Adenocarcinoma
33%
Pulmonary Metastasis
33%
Complete Response
33%
Partial Response
33%
Toxic Reaction
33%
Divided Dose
33%
Serum Triglycerides
33%
Advanced Squamous Cell Carcinoma
33%
Previous Chemotherapy
33%
Metastatic Colorectal Adenocarcinoma
33%
13-cis-retinoic Acid
33%
Granulocytopenia
33%
Pharmacology, Toxicology and Pharmaceutical Science
Colorectal Carcinoma
100%
Recombinant Alpha2a Interferon
100%
Phase II Trials
100%
Isotretinoin
100%
Squamous Cell Carcinoma
50%
Disease
25%
Neoplasm
25%
Neurotoxicity
25%
Biological Product
25%
Triacylglycerol
25%
Lung Metastasis
25%
Colon Carcinoma
25%
Granulocytopenia
25%
Patient History of Chemotherapy
25%